Cellix Bio Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Out of Business
Cellix Bio General Information
Description
Operator of a drug discovery platform intended to develop targeted therapies for patients. The company's platform helps to create new medicines that modulate several targets in the disease pathway, which potentially improves efficacy and minimizes risk in the discovery and development process, enabling healthcare professionals to treat chronic ailments and reduce recovery time.
Contact Information
Website
www.cellixbio.comCorporate Office
- New Jersey Innovation Technology-Enterprise Development Center
- 211 Warren Street
- Newark, NJ 07103
- United States
Corporate Office
- New Jersey Innovation Technology-Enterprise Development Center
- 211 Warren Street
- Newark, NJ 07103
- United States
Cellix Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 23-Feb-2025 | Completed | Out of Business | |||
| 4. Later Stage VC | 18-Mar-2021 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC | 19-Oct-2017 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 07-Aug-2017 | $3.9M | $3.9M | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
Cellix Bio Comparisons
Industry
Financing
Details
Cellix Bio Competitors (16)
One of Cellix Bio’s 16 competitors is Neurotez, a Private Equity-Backed company based in Jersey City, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neurotez | Private Equity-Backed | Jersey City, NJ | ||||
| Centrexion Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ | ||||
| Bridge Therapeutics | Venture Capital-Backed | Birmingham, AL |
Cellix Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cellix Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cellix Bio Investments & Acquisitions (2)
Cellix Bio’s most recent deal was a Merger/Acquisition with AvacaPharma. The deal was made on 04-Aug-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AvacaPharma | 04-Aug-2020 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Cellix Bio (Acquired 2018) | 06-Feb-2018 | Secondary Transaction - Private | Biotechnology |
Cellix Bio Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| AvacaPharma | Jaggayyapeta, India | 2016 | |
| Cellix Bio (Acquired 2018) | Hyderabad, India | 2014 |
Cellix Bio FAQs
-
When was Cellix Bio founded?
Cellix Bio was founded in 2014.
-
Where is Cellix Bio headquartered?
Cellix Bio is headquartered in Newark, NJ.
-
What is the size of Cellix Bio?
Cellix Bio has 11 total employees.
-
What industry is Cellix Bio in?
Cellix Bio’s primary industry is Drug Discovery.
-
Is Cellix Bio a private or public company?
Cellix Bio is a Private company.
-
What is Cellix Bio’s current revenue?
The current revenue for Cellix Bio is .
-
How much funding has Cellix Bio raised over time?
Cellix Bio has raised $15.1M.
-
Who are Cellix Bio’s competitors?
Neurotez, Centrexion Therapeutics, Ability Pharma, Bristol-Myers Squibb, and Bridge Therapeutics are some of the 16 competitors of Cellix Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
